125 related articles for article (PubMed ID: 12679193)
1. Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells.
Markovits J; Wang Z; Carr BI; Sun TP; Mintz P; Le Bret M; Wu CW; Wu FY
Life Sci; 2003 May; 72(24):2769-84. PubMed ID: 12679193
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
[TBL] [Abstract][Full Text] [Related]
3. A Cdc25A antagonizing K vitamin inhibits hepatocyte DNA synthesis in vitro and in vivo.
Carr BI; Wang Z; Wang M; Kar S; Wilcox CS; Rosi K; Southwick E; Lazo JS
J Mol Biol; 2003 Feb; 326(3):721-35. PubMed ID: 12581635
[TBL] [Abstract][Full Text] [Related]
4. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.
Tamura K; Southwick EC; Kerns J; Rosi K; Carr BI; Wilcox C; Lazo JS
Cancer Res; 2000 Mar; 60(5):1317-25. PubMed ID: 10728693
[TBL] [Abstract][Full Text] [Related]
5. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase.
Wu FY; Sun TP
Eur J Cancer; 1999 Sep; 35(9):1388-93. PubMed ID: 10658532
[TBL] [Abstract][Full Text] [Related]
7. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
8. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N
Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
11. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
Kar S; Wang M; Ham SW; Carr BI
Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
[TBL] [Abstract][Full Text] [Related]
12. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
Iavarone A; Massagué J
Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
[TBL] [Abstract][Full Text] [Related]
13. Cdc25A protein phosphatase: a therapeutic target for liver cancer therapies.
Wang Z; Kar S; Carr BI
Anticancer Agents Med Chem; 2008 Dec; 8(8):863-71. PubMed ID: 19075569
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
[TBL] [Abstract][Full Text] [Related]
15. The effects of GM-CSF, steel factor and MIP-1alpha on the expression and activation of Cdc25A phosphatase in Mo7e cells.
Reid S; Broxmeyer HE
Cytokines Cell Mol Ther; 1999 Sep; 5(3):129-38. PubMed ID: 10641570
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
17. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
Park WH; Kim ES; Kim BK; Lee YY
Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells.
Sun LK; Yoshii Y; Miyagi K
J Neurooncol; 2000 Mar; 47(1):31-8. PubMed ID: 10930097
[TBL] [Abstract][Full Text] [Related]
19. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]